study:
  name: SSD Causal Effect Analysis
  version: 1.1.0
  author: Ryhan Suny
  institution: Toronto Metropolitan University
  team: Car4Mind Research Team
  supervisor: Dr. Aziz Guergachi
temporal:
  reference_date: '2015-01-01'
  censor_date: '2015-06-30'
  exposure_window_start: '2015-01-01'
  exposure_window_end: '2016-01-01'
  outcome_window_start: '2016-07-01'
  outcome_window_end: '2017-12-31'
  covid_cutoff_date: '2020-03-01'
cohort:
  min_age: 18
  min_observation_months: 30
  max_charlson_score: 5
  exclude_palliative: true
  palliative_codes:
  - V66.7
  - Z51.5
  opt_out_column: OptedOut
exposure:
  min_normal_labs: 3  # CAUTION: No validated administrative data algorithms exist
  min_symptom_referrals: 2  # CAUTION: Referral patterns documented but not validated
  min_drug_days: 180  # CAUTION: Medication patterns recognized but not algorithmically validated
  symptom_code_regex: ^(78[0-9]|799)
  # RESEARCH GAP: Administrative data markers lack sensitivity/specificity validation
  # Current approach represents novel algorithm development requiring validation
  drug_atc_codes:
    anxiolytic:
    - N05B
    - N05C
    analgesic:
    - N02B
    hypnotic:
    - N05CH
    antidepressant:
    - N06A
    anticonvulsant:
    - N03A
    antipsychotic:
    - N05A
  drug_name_patterns:
  - ZOPICLONE
  - ZOLPIDEM
  - BUSPIRONE
  - BENZODIAZEPINE
  - GABAPENTIN
  - PREGABALIN
nyd:
  codes:
  - '799.9'
  - V71.0
  - V71.1
  - V71.2
  - V71.3
  - V71.4
  - V71.5
  - V71.6
  - V71.7
  - V71.8
  - V71.9
long_covid:
  icd_codes:
  - U07.1
  - U09.9
  text_patterns:
  - post-acute COVID
  - long COVID
  - post COVID
autoencoder:
  input_features: 56
  encoding_dim: 16
  hidden_dim: 32
  regularization: 1.0e-05
  epochs: 100
  batch_size: 256
  validation_split: 0.2
  early_stopping_patience: 10
propensity_score:
  method: xgboost
  gpu_enabled: true
  max_depth: 6
  learning_rate: 0.1
  n_estimators: 100
  weight_truncation_percentiles:
  - 1
  - 99
  caliper: 0.05
  matching_ratio: '1:1'
causal:
  methods:
  - tmle
  - double_ml
  - causal_forest
  bootstrap_iterations: 1000
  confidence_level: 0.95
robustness:
  placebo_outcomes:
  - dental_visits
  - eye_exams
  e_value_calculation: true
  sensitivity_analyses:
  - unmeasured_confounding
  - misclassification
  - selection_bias
mc_simex:
  enabled: true  # Using DSM-5 validated parameters from large-scale meta-analysis
  sensitivity: 0.78  # PHQ-15 meta-analysis (Hybelius et al., 2024) - 305 studies, 361,243 participants
  specificity: 0.71  # PHQ-15 cutoff ≥6 performance (JAMA Network Open 2024)
  # DSM-5 vs DSM-IV paradigm shift: DSM-5 SSD identifies 45.5% vs DSM-IV 92.9% (Claassen-van Dessel, 2016)
  # Combined approach achieves 69% sensitivity, 70% specificity (SSS-8 + SSD-12)
  # References:
  # - Hybelius, J., et al. (2024). JAMA Network Open. doi:10.1001/jamanetworkopen.2024.46603
  # - Claassen-van Dessel, N., et al. (2016). J Psychosom Res. doi:10.1016/j.jpsychores.2016.01.004
  bootstrap_samples: 100
  lambda_values:
  - 0
  - 0.5
  - 1.0
  - 1.5
  - 2.0
  use_bias_corrected_flag: false
paths:
  checkpoint_root: Notebooks/data/interim
  derived_data: data_derived
  results: results
  figures: figures
  reports: reports
  code_lists: code_lists
random_state:
  global_seed: 42
  numpy_seed: 42
  tensorflow_seed: 42
  torch_seed: 42
costs:
  pc_visit: 56.02  # Primary care average cost (CIHI National Physician Database 2020-2021)
  ed_visit: 628  # Emergency department average cost (CIHI data, national average)
  specialist_referral: 180  # PLACEHOLDER - Requires OHIP specialist fee validation for 2015-2017
  lab_test: 35  # PLACEHOLDER - Requires laboratory fee schedule 2015-2017
  medication_per_day: 5  # PLACEHOLDER - Requires pharmaceutical cost data
  # References:
  # - CIHI. (2021). National Physician Database, 2020-2021. Canadian Institute for Health Information.
  # - CIHI Emergency department cost data (national average $628 CAD)
  # TODO: Obtain historical OHIP fee schedules for study period 2015-2017
analysis:
  baseline_encounter_rate: null
  # DSM-5 SSD performance targets based on 2024 meta-analysis
  target_auc: 0.79  # PHQ-15 upper range for somatoform disorders (Hybelius et al., 2024)
  minimum_auc: 0.63  # PHQ-15 lower range threshold (95% CI: 0.50-0.76)
  best_combined_auc: 0.84  # SSS-8 + SSD-12 combined approach (95% CI: 0.81-0.87)
  # Population-specific considerations:
  # - Western populations: Higher cutoffs (PHQ-15 ≥9, SSD-12 ≥23-26)
  # - Asian populations: Lower cutoffs (PHQ-15 ≥4-5, SSD-12 ≥16)
  # - Administrative data algorithms: No validated studies exist (critical research gap)
logging:
  level: INFO
  format: '%(asctime)s  %(levelname)-8s  %(message)s'
dvc:
  remote_name: myremote
  cache_dir: .dvc/cache
performance:
  n_jobs: -1
  chunk_size: 100000
qc:
  max_missing_percent: 5.0
  min_cohort_size: 200000
  max_smd_weighted: 0.1
  min_effective_sample_size: 100000
